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1. Introduction
Dynamic, variable, and diverse overtime and in action, the entire effort of the human body is 
to survive. Whether preplanned, i.e. innate immune reactions, or partly planned, i.e. adaptive 
immunity, immunity has evolved to counteract changes. Human immune response follows 
the inexorable schemes based on four main principals of action:
First – Early detection of unwelcome factor of change and activation of response systems.
Second – Setting the stage for an effective, least interfering, response with normal body func-
tion and activation of systemic responses.
Third – Activation of long-term survival and adaptation signals, and natural repair systems.
Fourth – Timely termination of the response and learning from the experience if need be!
The advent of molecular genetics, molecular pathophysiology, utilization of new imaging 
techniques, and advances in bioinformatics and health data, have shed light over novel etio-
logic factors of disorders and opened eyes to more pieces of the puzzle of diseases of the 
human body. Researchers in clinical medicine and basic science are deciphering the complex 
trails by which our immune response is both regulated by and controls many functions of a 
living creature, from fundamentals of a local response at the site of injury to the neurodevel-
opmental function of immune pathways in the developing brain, and to the inclusive mecha-
nisms by which immunity regulates one's longevity and survival. It is not at all a daring claim 
that our immune system is the executive element in almost every defense mechanism of the 
human body to counteract threats. Whether it be invading microorganisms into the guts, an 
abnormally proliferating cell in the lining of our lungs, a blood clot in one of the cerebral 
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arteries, aberrant aggregation of cholesterol in endothelium lining of the coronary artery, or 
an aging cell in the macula of the eye. Immune aspects of physiology and pathology of the 
human being are now the prevailing notion in research, therapeutic modalities, and day-to-
day practice of clinicians.
This book is presented as the result of an effort to provide basics to this vast area of growing 
knowledge, on the basic actions of the immune system in health and disease. Uncertain nature 
of the “change”, temporally and regionally, necessitates a 24-hour alert system to summon 
immune effectors and exert the proper scenario of action. The effector cells of the immune 
system are therefore distributed in a tightly regulated manner all throughout the body and 
over time. The mucosal-associated lymphoid tissue comprises the largest pool of immune 
effectors, followed by bone marrow and spleen, which are the primary training and regula-
tion sites of immunity. Most interesting is that each and every organ system and each cell in 
the body is conferred with the intrinsic ability to respond to change, injury, or an adverse 
event, and set off a cascade of adaptation or maladaptation.
This makes us to the important crosstalk of immunity with three major regulatory bodies in 
human body. Immunity acts in consort with hemostatic response, neuroendocrine system, 
and circulatory/lymphatic system to exert potent internal regulatory signals. Later on, in this 
section, we look briefly at the fundamentals of the function of the human immune system to 
be able to move on to the exciting new dimensions of the role of immunity in cancer immunol-
ogy, immunology of transplantation, autoimmunity, and immunodeficiencies.
Conventionally, there has been a trend to define the immune system, first by introducing the 
immune mediators, cells and organs involved in various responses, and then by dividing the 
responses into “innate” and “adaptive or acquired” response.
The innate immunity is as diverse and ancient as the structures of different parts of the 
human body. Each organ system has developed over time, barriers to minimize the scope 
of pathogen invasion, or better neutralize the attack at the site of entry. We believe that the 
evolution of human immune system is the product of and currently shaped by, an everlasting 
struggle with rapidly reproducing and frequently changing microbial pathogens. The various 
mechanisms of innate immunity are developed in order to quickly identify the stereotypes 
in pathogen structures [i.e., pathogen-associated molecular patterns (PAMPs)] and provide 
either mechanical barriers or respond by secretion or cell surface expression of antagonizing 
molecules, most importantly known as antimicrobial peptides. Pattern recognition in innate 
immunity is based on, but not confined to, identification of peptides, as well as carbohydrates 
and pathogen-associated nucleic acid segments [1]. Inflammation is a transitory and ongoing 
nonspecific mechanism of innate immunity. A full-armed activation of defense and repair 
mechanisms, and involvement of the pathogen-specific, acquired immune responses follow 
the initial inflammatory response. Inflammation could be defined as a harmonic array of acti-
vation of plasma proteins (complement system, antimicrobial peptides such as defensins and 
cathelicidins, cytokines, and vasoactive mediators), circulating and infiltrating leukocytes 
(polymorphonuclear leukocytes, lymphocytes, macrophages/monocytes etc.). Endothelial 
lining of the vessels and indolent cells of the parenchyma are known as non-specified, yet 
highly active players of inflammation.
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The primary goal of the inflammatory response is to recruit immune cells to the site of inva-
sion. Yet, failure to remove the pathogen from the site of entry, as happens following the 
invasion of Mycobacterium tuberculosis to a hilar lymph node of the lung, failure to termi-
nate the response, such as when antigen:antibody complex deposits in glomerular basement 
membrane a few weeks after streptococcal pharyngitis, excessive response to a benign patho-
gen, when resident alveolar macrophages, eosinophils, and neutrophils are drawn to the site 
where Aspergillus spores penetrate the respiratory system, each underlie formation of differ-
ent types of immune diseases.
Before we move to describe the common scenarios by which the immune system operates its 
actions and the distinct disciplines in emerging fundamental of cancer immunology, immu-
nology of transplants, systemic and organ-specific autoimmune disorders, and immunode-
ficiencies, let us move to the building blocks of immunity, tissue/cellular components of the 
immunity.
2. Cells of the immune system
2.1. Granulocytes
The polymorphonuclear granulocytes (PMNs) or neutrophils are the soldiers in the front 
of acute infection and inflammation. Other two types of granulocytes, the eosinophils and 
basophils deliver target specific phagocytosis and cytotoxicity. Ingestion and degradation of 
microbes and cellular debris, from the site of infection or tissue damage, is the primary role 
of PMNs. They do so with the help of surface display of pathogen-associated molecular pat-
tern receptors, such as toll-like receptors, NOD-like receptors, and also receptors for the con-
stant part of various antibodies (e.g., fc IgG) and complement system receptors (e.g., C3a). The 
macrophages, in turn, appear late in the inflammatory response, continue phagocytosis and 
elaborate long-term tissue remodeling mechanisms. IL-8 and specific chemotactic agents from 
injured cells, and complement mediators (C3 and C5) in the plasma, attract neutrophils, eosin-
ophils, and basophils to the site of infection. Together they produce soluble products, IL-5, 
eotaxin, histamine, or reactive nitrogen and oxygen species, exerting potent cytotoxic or chemo-
tactic on the bacterial, viral, protozoal, or allergic pathogen. Inborn errors in adhesion, migra-
tion, or degranulation of granulocytes are the basis of leukocyte adhesion deficiency (LAD) 
and chronic granulomatous disease (CGD), the two types of “primary immunodeficiencies.”
2.2. Lymphocytes
Lymphocytes are categorized into four types, based on function, the B lymphocytes, T lym-
phocytes, natural killer cells (NKCs), and NK T cells. They all share the same common lym-
phoid progenitor in the bone marrow, yet, the first two cell lines develop their clonally unique 
surface receptor immunoglobulin (Ig) or T-cell receptors (TCR), in the bone marrow, ensuring 
strict selection criteria, before they release into the periphery for further maturation. As for 
the B cells, they later undergo involution into mature antibody producing plasma cells. The 
safe/nonsafe and self/nonself discrimination, the paradigm of action of the immune system, is 
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perceived to be a primary consequence of T-cell discrimination of self-/nonself-antigens. No T 
cell can recognize a self-protein unless it is endocytosed, digested, and presented in the form 
of a complex with either type of major histocompatibility (MHC) molecules, on the surface 
of an antigen presenting cell (APC). In contrast, the antibody on the surface of B cells can 
recognize and reproduce soluble immunoglobulins, as they travel from lymph nodes to the 
blood and the sites of invasion, against a wide array of antigens from polysaccharides, lipids, 
nucleic acids, and larger proteins.
By virtue of their membrane expression of killer cell inhibitory receptors (KIR) and CD16, NK 
cells and NK T cells, are omnipresent circulating security check systems. Via a direct cell-to-
cell contact, mediated by KIR, the NK cells “scan and inspect” almost every cell type in the 
body, for uneventful intracellular events, a neo-epitope or a mutant protein from neoplastic 
alteration of the cell or a viral antigen, etc. Antigenic particles formed in this process are pre-
sented by class I of MHC molecules and consist of peptides of various sources, mostly from 
denatured and worn out proteins after they undergo normal senescence and degradation by 
proteasome complex. The NK cells own a unique receptor for the constant part of the IgG, 
that upon recognition of the Ag:Ab complex, mediates a burst out of cytotoxic granules from 
the lymphocyte. A targeted, direct cell-to-cell cytotoxicity is the result. NK cells provide the 
first line of antitumoral/antiviral defense of the immunity, while the machinery of antigen 
presentation to cytotoxic and helper variants of T cells is setting off in action.
2.3. Antigen presenting cells (APCs)
Antigen presentation is the groundwork for various types of cells that are active in displaying 
protein antigens to the naïve T-cell lymphocytes. The monocytes/macrophages, constituents 
of the reticuloendothelial system, the B cells, and foremost, the dendritic cells, are labeled as 
APCs, based on their mutual ability to express both class I and class II MHC molecules. Some 
APCs (monocytes/macrophages), particularly express surface receptors for Fc gamma of IgG 
and C3b and are very potent phagocytosis. Some, like dendritic cells, are less potent phago-
cytes but have evolved into very efficient antigen detectors. Conventional dendritic cells are 
strategically located at the body entrance sites, to capture microbes and to migrate to T-cell 
zones of sentinel lymph nodes to instruct further deployment of adaptive immune response. 
Cross-talks between TCR, costimulatory molecules on APCs, and the MHC class II molecules 
are the core of a series of tightly regulated mechanisms that orchestrate a robust and accurate 
plan to counteract offenses.
2.4. Lymphoid tissues
It is an incomplete introduction on immune cells if one does not mention the diffuse, yet 
amazingly systematized organs with a lead role in human immunity. While every cell and 
organ in the body is endowed with a primary and nonspecific defense system (e.g., muco-
sal membrane of mouth, lung, etc., special circulation conduits of the GI system, the urine 
flushing the urethra, or the mucociliary escalator of the bronchi), there are accumulations 
of lymphoid tissue in human body in charge of training lymphocytes, fostering immune 
interactions, and providing long-term reservoirs for memory cells residence. Based on the 
main lymphocyte population, they are divided into primary (Thymus and bone marrow) 
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and secondary (lymph nodes, spleen, and mucosal-associated lymphoid tissues). Primary 
lymphoid organs, harbor lymphocytes proliferation, selection, clonal expansion, and matu-
ration. While the secondary organs, serve as homing and expansion sites for mature lympho-
cytes and facilitate acquired immune response via exclusive structural delicacies.
3. Stories about the immune system
3.1. Inflammation
Inflammation, as described, is the effort of injured cells, to communicate the danger signal, on the 
spot, to the first-line innate mechanisms to minimize the invasion hazards. These include, but are 
not confined to, vascular response, regarding vasodilation, increase in permeability, and activa-
tion of endothelial cells, leading to cellular response, with an increase in leukocyte chemotaxis, 
adhesion, and transmigration, into extracellular tissue. Infection is the most common trigger for 
inflammation, yet, tissue necrosis, aseptic trauma with or without necrosis, foreign bodies, and 
in the case of inflammatory disorders, hypersensitivity to a sustained assault or autoantigens, 
could all be the souls behind the face of inflammation. Resident phagocytes, dendritic cells, and 
epithelial cells, and depending on whether endothelial damage has occurred, platelets are the 
first to confront the products of tissue assault. These cells recognize the danger via the pathogen/
danger-associated molecular pattern (PAMP) receptors. They produce a wide array of danger 
signals including proinflammatory cytokines, and in turn respond to histamine, thrombin, TNF-
α, IL-1, and IL-6 by secretion of chemotactic agents, further facilitating leukocyte transmigration.
The endothelial expression of adhesion and selectin molecules (e.g., E-selectin surfaced in 
response to TNF-α and IL-1), and their interaction with a multitude of surface integrin and cell 
adhesion molecules on leukocytes, facilitates leukocytes allocation to the infection site. Activated 
indigenous or infiltrated phagocytes, in turn, ingest microorganisms and dead cells, produce 
reactive oxygen and nitrogen species, extracellular digestive enzymes, and products of lipoxy-
genase cascade such as leukotrienes and prostaglandins. These, together with the complement 
system and antibody response, form the main body of chemical moderators of inflammation.
The face of an inflammatory response changes when antigen presenting cells set the stage for 
specific recognition of the antigens and presentation to T cells. Antigen-specific T cells, mac-
rophages, circulating plasma cells, and memory B cells are leading characters of immunity, in 
a durative inflammation.
3.2. B-cell and T-cell development and maturation
Genetic recombination is the most noteworthy feature acquired by the immune system, 
endowing an adaptive ability to generate a limitless array of receptors, while maintaining 
genetic stability and frugality of genetic material of a vertebrate cell.
The B-cell receptor (BCR) light and heavy chains (IgL and IgH), and the TCR α, β, γ, and δ 
chains, each form as result of a matchless system of genetic recombination/rearrangement 
of V(D)J regions, their assembly with different types of immunoglobulin constant regions to 
form an clonally unique and specific receptor for two main types of lymphocytes.
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Either as a soluble immunoglobulin or as B-cell surface receptor, the BCR is a heterodimer of 
two heavy chains (with five types of constant regions, to which they are designated for IgG, 
IgA, IgM, IgD, and IgE) and two light chains, either kappa,or lambda, based on the sequence 
of their constant region. The TCR is either an αβ chains or a γδ chains heterodimer, with the 
αβ being the most common type. Alike Ig heterodimers, each of the α, β, γ, or δ chains also 
has a constant and variable region.
Within the precursors of B cell and T cell in the bone marrow, the immunoglobulin gene 
segment undergoes a sequential allelic exclusion to recombine one of each type of V, D, or J 
genes at each locus, at a time. If the rearrangement is productive, and full-length light and 
heavy chains are produced, the resultant, pro–B cells and pro–T cells, undergo selection either 
through bone marrow stromal cells for B cells or the cortex epithelial and medullary cells 
of the thymus. Induction of “central tolerance” in lymphocytes, follows one principle, that 
is high avidity and low avidity self-antigen recognition are both discouraged, and only the 
nonantigen-responsive lymphocytes are selected and given a chance to survive. These later 
migrated from primary lymphoid organs to the periphery to be exposed to a set of secondary 
immune surveillance mechanisms or “peripheral tolerance.”
Receptor selection of TCR is different from the BCR, as TCR must acquire the potential to 
react to self-antigen-MHC complexes, rather than soluble antigens, an eligibility acquired via 
positive and negative selection. Only thymocytes that can bind to bare MHC class I and II in 
the cortex of the thymus (positive selection), and later unable to bind or bind with low affinity 
to the medullary expressed self-antigen-MHC complexes (negative selection), will receive life 
signals to release to the periphery. Pre–B cells with “high avidity self-antigen recognition” are 
either given a second chance to rearrange their variable V(D)J region of the light chain (with 
the remaining options of the same gene or their pair on the homologous chromosome), before 
either receiving a go-ahead signal or undergoing apoptosis.
A final leap is required for a B cell to get matured, and that is, the naïve B cell undergoes 
switching of the receptor subtype (class switching), changing the antibody subtype of the 
BCR from IgM to IgG, and later into other immunoglobulin subtypes to be able to mediate 
various types of humoral responses to different antigens. The peripheral encounter of a B cell 
or T cell, bearing a self-reactive receptor, evokes peripheral tolerance mechanism, leading to 
activation-induced death or anergy of the autoreactive lymphocytes.
3.3. Humoral and cellular response to an infection
In this paragraph, we look briefly into a typical humoral and cellular response to an extracellu-
lar pathogen; e.g., Streptococcus pyogenes cultivating the throat. Acute innate immune response 
to an infection is neutrophils infiltration, chemo-attraction of distinct populations of leukocytes, 
and secretion of TNF-α, IL-1, IL-6, nitrous oxide, and proteases. Next, macrophages, dendritic 
cells, along with other tissue-specific and nonspecific APCs, present parts of the degraded 
pathogen on their surface MHC receptors, which are in this case the class II of MHC molecules.
Regulation of lymphocyte circulation is essential, for appropriate interaction of APCs and 
lymphocytes to happen. An elaborate system of chemokines and surface receptors, makes 
sure that the meticulously selected mature B and T lymphocytes, not only travel in a nonstop 
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trip, trafficking in and out of secondary lymphoid organs, but also, receive appropriate “hom-
ing signals,” to the site or sites where the interaction of immune cells predominantly occur.
Recognition of antigens via Ig or TCR provides the primary signal for lymphocyte activation, 
named as signal 1. As a consequence of the negative selection of lymphocyte in bone marrow and 
thymus, T lymphocytes that bind with moderate to low affinity to MHC/antigen complex, do not 
receive a “go” signal for maturation, unless triggered with costimulatory molecules, usually from 
activated APCs, that provide the additional “signal 2.”The innate immune response activates 
APCs for a more efficient phagocytosis and antigen presentation to T cells, upregulating costimu-
latory molecules and expressing IL-2 that is essential for T-cell proliferation and differentiation.
A good sample of APCs and lymphocytes reciprocal signals and cross-activation during for-
mation of adaptive immune response is when activated B cells, act as antigen presenting cells, 
give and receive signal 2 for maturation, to and from naïve T lymphocytes. Cross-bridging of 
two Ig on the surface of B cell activates B cells and mediates a “receptor-mediated internal-
ization of antigen,” which is then presented on the surface as a complex with MHC class II 
molecule and upregulation of CD80 (B7). The antigen/MHC complex on the B-cell membrane 
provides signal 1 for the naïve T cell. Later, CD80 binding to CD28 (a constitutive B7 receptor 
on T cells) provides signal 2, and the activated T cell upregulates CD40L (CD154), a costimula-
tor for B-cell maturation, class switching, and immunoglobulin expression.
4. What does the immunity has to say about?
4.1. Immunology of neoplasia
Footprints from the immune system could be found in many aspects of cancer pathogenesis. 
Cancer is not only defined now, by the genetic mechanisms that culminate in transformed cells 
with a senseless tendency to proliferate but also as an everyday challenge of the body with cells 
that undergo subtle yet malignant intracellular changes and mutations. Two theories of “cancer 
immune surveillance” and “cancer immune editing” focused on the crucial role of immunity 
in cancer [2]. The identification of tumor’s ability to selectively and efficiently suppress com-
ponents of the immune system in favor of its longevity and invasion put a further spin on this 
notion [3]. Immune elimination of cancer releases tumor-specific antigens and danger signals 
and creates a tumor-edited immunity. Everyone working in the field of cancer immunology is 
familiar with new entries added to the dictionary of cancer, tumor antigens, tumor infiltrating 
lymphocytes, and myeloid-derived suppressor cells [4]. Finally, the advent of drugs targeting 
the cutting-edge knowledge of immune culprits of cancer and “tumor-specific antigens” has 
brought hope for effective cancer immunotherapy for tumor suppression or even tumor abla-
tion [5], and cancer vaccination has become a trending topic in cancer research [6].
4.2. Immunology of infection
It was the microbes that drew our attention to our immune system and led us to know more 
about it. Studying immunology has diverged into many branches and disciplines, yet study-
ing the immunity of infection still has galaxies to explore. Microbes are the primary reason for 
Introductory Chapter: Introduction on Physiology and Pathology of Immunology
http://dx.doi.org/10.5772/intechopen.70429
7
the evolution of immunity, the phylogenetic of this phenomenon tells us that if it were not for 
smart eukaryotes, learning how to fight back prokaryotic within a complex, multipotent herd, 
the human system would have never maturated into its current shape and complexity. The 
danger theory and the self-/nonself-paradigm that reigned the knowledge of immunology 
for years was a direct revelation from years of studying host defense to infectious agents [7].
The emergence of HIV/AIDS pandemic has made researchers to turn a clever eye on “immu-
nity in infection” and “infections of immunity.” Rays of hope have shed over this situation 
with endeavors to design and test an ultimate HIV vaccine [8].
4.3. Immunology of organ transplant
Transplant of solid organs was restricted, first due to technical problems of heavy surgeries, 
infections, and hardships of ligating blood flow to major organs for long. Next, the daring 
first transplant surgeons became aware of the fact that the first reason of the transplant failure 
was not complications of the surgery, but rather it was the failure of the transplanted organ 
that killed the patient. The development of efficient and target specific immunosuppressive 
therapy and biological agents has turned organ transplant, into a routine therapeutic option 
for various types of end-stage organ failures. Nowadays, it is a problem of organ supply, as 
up to one-third of the patients waiting on the list die before a donor can be found. Cadaveric 
organ transplant, marginal donor transplants are still facing a dilemma to achieve a long-term 
reduction in mortality [9]. The overall success rate, however, is approximated between 80 and 
90%, and it is now the duty of immunological research to open a landscape for alternatives of 
organ donation, such as xenografts, to overcome the problem of organ shortage [10].
4.4. Autoimmunity
Autoimmunity is a term used to describe the chronic response of the immunity to self-anti-
gens, resulting in tissue damage. Autoimmunity happens in a sequence of distinct phases, 
from genetic susceptibility, which involves at least one of the factors; impaired tolerance, 
reduced production, or activation of the regulatory subset of T cells, impaired clearance of 
antigen: antibody complexes, etc. Next, there is a trigger, an initiation phase that the self-
antigens are exposed to the faulty system of antigen recognition, or a full-blown immune 
response that activates the dormant nonresponsive alive autoreactive lymphocytes. The ini-
tiation of the reaction further releases autoantigens and results in progression of disease and 
establishment of chronic tissue damage. Credentials for these phases have been investigated 
regarding specific auto-antibodies, markers of initiation, and progression and clinical stages 
of the disease. The next challenge would be the implementation of this knowledge into a 
precise diagnosis, appropriate monitoring, and care of patients with autoimmune diseases.
4.5. Immunodeficiencies
Immunodeficiencies could be divided into two groups of inherited (primary) or acquired 
(secondary) immunodeficiencies, the latter group being a cause of acquired factors such as 
HIV infection, protein-losing enteropathy, malnutrition, cancers, or immunosuppressive 
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drugs that impair immune-related functions in a previously healthy immune system. Primary 
immunodeficiencies are a heterogeneous group of disorders, caused by a gene defect, leading 
to defect(s) of the immune system. More than 300 different types of primary immunodeficien-
cies have already been described [11]. Haematopoietic stem cell therapy, immunoglobulin 
replacement, and the use of antibiotics have extended lives of patients with immunodeficien-
cies to an almost normal span [12].
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